Medical Monitor- Hepatobilliary/Pancreatic cancer
Lindus HealthPart Time
Expert & Leadership (9+ years)
Candidates must possess a Bachelor's Degree and at least 3 years of experience in oncology and/or clinical trials, with a deep understanding of study start-up processes. Strong persuasive, strategic, and motivational skills are essential, along with a proven track record of high personal performance. The role requires exceptional organizational skills, meticulous attention to detail, persistence, resilience, strong relationship-building abilities, and advanced written and oral communication, analytical, interpersonal, and problem-solving skills. Regular travel, up to 40%, is also required.
The Clinical Research Liaison will serve as the primary point of contact for research and care teams regarding TIME trial activities, maintaining regular communication with targeted accounts. Responsibilities include building relationships with key client stakeholders, drafting and executing strategic operational plans to meet JIT standards, and providing ongoing education about clinical trial access. The liaison will also participate in research steering committees, collaborate with internal teams to execute key deliverables, and utilize knowledge of oncology and clinical trials to identify site resource gaps and onboard sites. Additionally, they will assist in creating innovative tactics to ease site burden, incorporate client feedback into product improvements, contribute to marketing collateral, attend relevant conferences, and perform associated administrative activities, including oversight of program coordinators.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.